MicroPort EP Valuation Multiples

MicroPort EP is valued at $1.3B as of November 2026, a 14.1x revenue multiple. In the last 12 months, MicroPort EP revenue was $82M and MicroPort EP EBITDA was $15M.

MicroPort EP Overview

About MicroPort EP

Shanghai MicroPort EP Medtech Co Ltd is engaged in the research and development, production and sales of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment.


Founded

2010

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $82M
EBITDA: $15M

EV

$1.2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MicroPort EP Financials

MicroPort EP reported last 12-month revenue of $82M and EBITDA of $15M.

In the same LTM period, MicroPort EP generated $46M in gross profit, $15M in EBITDA, and $9M in net income.

Revenue (LTM)


MicroPort EP P&L

In the most recent fiscal year, MicroPort EP reported revenue of $70M and EBITDA of $13M.

MicroPort EP is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 18%, and net margin of 11%.

See analyst estimates for MicroPort EP
LTMLast FY202320242025202620272028
Revenue$82M$70M$49M$61M$70M
Gross Profit$46M$40M$31M$36M$40M
Gross Margin56%58%64%59%58%
EBITDA$15M$13M$5M$13M$13M
EBITDA Margin18%18%11%22%18%
EBIT Margin12%8%(6%)9%8%
Net Profit$9M$8M$844K$8M$8M
Net Margin11%11%2%13%11%
Net Debt-($41M)---

Financial data powered by Morningstar, Inc.

MicroPort EP Stock Performance

MicroPort EP has current market cap of $1.3B, and enterprise value of $1.2B.

Market Cap Evolution


MicroPort EP's stock price is $2.85.

MicroPort EP share price increased by 12.3% in the last 30 days, and decreased by 12.2% in the last year.

MicroPort EP has an EPS (earnings per share) of $0.02.

See more trading valuation data for MicroPort EP
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.2B$1.3B3.5%12.3%8.7%-12.2%$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MicroPort EP Valuation Multiples

MicroPort EP trades at 14.1x EV/Revenue multiple, and 79.0x EV/EBITDA.

See NTM and 2027E valuation multiples for MicroPort EP

EV / Revenue (LTM)


MicroPort EP Financial Valuation Multiples

As of November 18, 2026, MicroPort EP has market cap of $1.3B and EV of $1.2B.

MicroPort EP has a P/E ratio of 142.6x.

LTMLast FY202320242025202620272028
EV/Revenue14.1x16.5x23.6x18.8x16.5x
EV/EBITDA79.0x91.5x217.6x86.0x91.5x
EV/EBIT121.3x196.9xn/m219.8x196.9x
EV/Gross Profit25.1x28.5x37.2x32.0x28.5x
P/E142.6x174.8xn/m173.5x174.8x
EV/FCFn/m(245.2x)(97.3x)n/m(245.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MicroPort EP Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MicroPort EP Margins & Growth Rates

MicroPort EP grew revenue by 20% and EBITDA by 19% in the last fiscal year.

In the most recent fiscal year, MicroPort EP reported gross margin of 58%, EBITDA margin of 18%, and net margin of 11%.

See estimated margins and future growth rates for MicroPort EP

MicroPort EP Margins

Last FY202420252026202720282029
Gross Margin58%59%58%56%
EBITDA Margin18%22%18%18%
EBIT Margin8%9%8%12%
Net Margin11%13%11%12%
FCF Margin(7%)6%(7%)3%

MicroPort EP Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth20%26%14%20%
Gross Profit Growth16%16%12%16%
EBITDA Growth19%153%(6%)19%
EBIT Growth67%(289%)12%67%
Net Profit Growth26%815%(1%)26%
FCF Growth(154%)(129%)(235%)(154%)

Data powered by FactSet, Inc. and Morningstar, Inc.

MicroPort EP Operational KPIs

MicroPort EP's Rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MicroPort EP's Rule of X is 69% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for MicroPort EP
LTMLast FY202320242025202620272028
Rule of 4043%38%---
Bessemer Rule of X80%69%---
S&M Expenses to Revenue28%10%13%10%10%
G&A Expenses to Revenue8%1%5%5%1%
R&D Expenses to Revenue13%14%28%19%14%
Opex to Revenue-50%69%50%50%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

MicroPort EP Competitors

MicroPort EP competitors include SonoScape, PROCEPT BioRobotics, Beijing Balance Medical, NovoCure, Staar Surgical, Nolato, Sansure Biotech, Arcs Co, Zhuhai Trinomab and Edge Medical.

Most MicroPort EP public comparables operate across Medical Devices, HealthTech and DeepTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
SonoScape$347M$35M3.6x3.2x35.3x26.6x
PROCEPT BioRobotics$308M($98M)4.0x3.2x(12.6x)(33.4x)
Beijing Balance Medical$93M$37M14.7x-36.8x-
NovoCure$655M($117M)1.6x1.5x(9.1x)46.5x
Staar Surgical$239M($37M)4.6x3.4x(29.8x)20.0x
Nolato$938M$157M1.4x1.4x8.6x8.7x
Sansure Biotech$246M$49M3.9x3.8x20.0x13.1x
Arcs Co$3.9B$181M0.2x0.2x4.6x4.8x

This data is available for Pro users. Sign up to see all MicroPort EP competitors and their valuation data.

Start Free Trial

MicroPort EP VC Funding History

Before going public, MicroPort EP raised $43M in total equity funding, across 1 round.

Last private valuation of MicroPort EP was $696M, after raising $43M in August 2020 from Grand Flight Investment, Shanghai Pudong Kechuang Group, CPE, and 3 other investors.


MicroPort EP Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Aug-20Undisclosed stageGrand Flight Investment; Shanghai Pudong Kechuang Group; CPE; CITIC; Shanghai Pudong Science and Technology Investment; E-Fund$43M$696MShanghai MicroPort EP MedTech Co., Ltd. is a specialist in electrophysiology (EP) technologies, offering a complete platform for electrophysiological interventional procedures with integrated solutions combining devices and equipment. The company has over 100 global patents, leads more than 20 research projects in China, and holds NMPA registration for 16 devices and CE marks for 14, with four in NMPA's innovative device review. Its products are used in over 500 EP centers in China and markets in Europe, Americas, and Southeast Asia. On August 6, 2020, MicroPort EP secured 300 million RMB (US$43 million) from strategic investors CPE (CITIC Private Equity), Grand Flight Investment, E Fund Management, and Shanghai Pudong Kechuang Group, achieving a post-money valuation of 4.8 billion RMB. This funding supports new product development and market expansion, positioning the company for rapid growth as the only Chinese firm providing comprehensive EP solutions. MicroPort EP has earned national awards for high-tech research, patents, and EP capabilities. The investment aligns with MicroPort Scientific Corporation's 2020 activities, which included external financing of about US$1 billion across subsidiaries amid COVID-19 challenges. Parent company revenue reached US$648.7 million in 2020, with EP-related segments like endovascular devices at US$68.5 million.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MicroPort EP

When was MicroPort EP founded?MicroPort EP was founded in 2010.
Where is MicroPort EP headquartered?MicroPort EP is headquartered in China.
Is MicroPort EP publicly listed?Yes, MicroPort EP is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of MicroPort EP?MicroPort EP trades under 688351 ticker.
When did MicroPort EP go public?MicroPort EP went public in 2022.
Who are competitors of MicroPort EP?MicroPort EP main competitors include SonoScape, PROCEPT BioRobotics, Beijing Balance Medical, NovoCure, Staar Surgical, Nolato, Sansure Biotech, Arcs Co, Zhuhai Trinomab, Edge Medical.
What is the current market cap of MicroPort EP?MicroPort EP's current market cap is $1.3B.
What is the current revenue of MicroPort EP?MicroPort EP's last 12 months revenue is $82M.
What is the current revenue growth of MicroPort EP?MicroPort EP revenue growth (NTM/LTM) is 25%.
What is the current EV/Revenue multiple of MicroPort EP?Current revenue multiple of MicroPort EP is 14.1x.
What is the current EBITDA of MicroPort EP?MicroPort EP's last 12 months EBITDA is $15M.
What is MicroPort EP's EBITDA margin?MicroPort EP's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of MicroPort EP?Current EBITDA multiple of MicroPort EP is 79.0x.
What is the current FCF of MicroPort EP?MicroPort EP's last 12 months FCF is $2M.
What is MicroPort EP's FCF margin?MicroPort EP's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of MicroPort EP?Current FCF multiple of MicroPort EP is 749.3x.
How many companies MicroPort EP has acquired to date?MicroPort EP hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies MicroPort EP has invested to date?MicroPort EP hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to MicroPort EP

Lists including MicroPort EP

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial